|
Volumn 20, Issue 9-10, 2002, Pages 1365-1368
|
Immune responses to an inactive vaccine against American cutaneous leishmaniasis together with granulocyte-macrophage colony-stimulating factor
|
Author keywords
Leishmaniasis; rhGM CSF; Vaccine
|
Indexed keywords
GAMMA INTERFERON;
INTERLEUKIN 5;
LEISHMANIA VACCINE;
PLACEBO;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
ANTIGEN PRESENTATION;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CYTOKINE PRODUCTION;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG SCREENING;
HUMAN;
HUMAN EXPERIMENT;
IMMUNE RESPONSE;
IMMUNITY;
NORMAL HUMAN;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SKIN LEISHMANIASIS;
SKIN TEST;
VACCINATION;
ADJUVANTS, IMMUNOLOGIC;
ANIMALS;
DOUBLE-BLIND METHOD;
GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTORS, RECOMBINANT;
HUMANS;
HYPERSENSITIVITY, DELAYED;
INTERFERON TYPE II;
INTERLEUKIN-5;
LEISHMANIA MEXICANA;
PROTOZOAN VACCINES;
VACCINES, INACTIVATED;
|
EID: 0037203803
PISSN: 0264410X
EISSN: None
Source Type: Journal
DOI: 10.1016/S0264-410X(01)00469-8 Document Type: Article |
Times cited : (32)
|
References (26)
|